Mark Chin Iterum Therapeutics PLC (ITRM) insider trading activity

ITRM Quotes by TradingView

Mark Chin is Director of Iterum Therapeutics plc. Currently has a direct ownership of 18,306 shares of ITRM, which is worth approximately $38,625. The most recent transaction as insider was on Jun 15, 2023, when has been sold 15,853 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.3K
0% 3M change
0% 12M change
Total Value Held $38,625

Mark Chin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
15,853 Added 46.41%
18,306 Ordinary Shares
Jun 23 2022
BUY
Exercise of conversion of derivative security
-
36,798 Added 50.0%
36,798 Ordinary Shares
Jul 28 2020
SELL
Other acquisition or disposition
-
11,857 Reduced 100.0%
0 Ordinary Shares

Also insider at

HARP
Harpoon Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
Director
PYXS
Pyxis Oncology, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
MC

Mark Chin

Director
Dublin, L2

Track Institutional and Insider Activities on ITRM

Follow Iterum Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

News

Receive news related to Iterum Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITRM